📊 Removal Estimates

Estimates based on drug properties and standard treatment parameters.

🩸

32.4 mL/min

Poorly Dialyzable

Minimal removal expected. Half-life: 80 hrs. No supplementation needed. Despite long half-life, clearance is low due to other factors.

Data Used:
✅ molar_mass, mw_factor, vd, vd_factor, half_life
⚠️ Missing: protein_binding

Free fraction: 0.5 Mw factor: 0.2 Vd factor: 1 Hl factor: 1.2 Half life: 80 hrs Half life category: Extended (> 72h)

🫀

0.4 mL/min

Low PD Clearance

Minimal removal expected. No supplementation needed. Half-life: 80 hrs.

Data Used:
✅ molar_mass, half_life
⚠️ Missing: protein_binding

Free fraction: 0.5 Half life: 80 hrs Half life category: Extended (> 72h)

🔄

Unable to Assess

Insufficient data for TPE risk assessment. Protein binding and Vd required.

Data Used:
✅ vd, half_life
⚠️ Missing: protein_binding

Half life: 80 hrs Half life category: Extended (> 72h)

🧪

High Effectiveness

Excellent candidate for hemoperfusion. Long half-life suggests significant removal possible. Effective in overdose. Rebound expected.

Data Used:
✅ vd, half_life

Half life: 80 hrs Half life category: Extended (> 72h)

Modality	Clearance/Value	Half-Life	Classification	Data Quality
Hemodialysis	32.4 mL/min	80 hrs	Poorly Dialyzable	Partial Data
Peritoneal Dialysis	0.4 mL/min	80 hrs	Low PD Clearance	Partial Data
Plasmapheresis (TPE)	Unable to Assess	80 hrs	N/A	Partial Data
Hemoadsorption	High Effectiveness	80 hrs	N/A	Complete Data

Hemodialysis: Estimates based on high-flux dialyzer (urea clearance 270 mL/min), Qb 300 mL/min, 4-hour session.
Peritoneal Dialysis: Estimates based on CAPD (Continuous Ambulatory Peritoneal Dialysis).
TPE: Risk assessment based on protein binding and volume of distribution.
Hemoadsorption: Effectiveness based on volume of distribution. Most effective for drugs with Vd < 0.2 L/kg.
Data Quality: Estimates with missing data use default assumptions. Consider adding missing data for more accurate predictions.
Clinical Note: These are descriptive estimates only. Always consult clinical guidelines and monitor drug levels when available.